Charles River Laboratories

Historical price data

Founded in 1947, Charles River Laboratories has grown to become one of the world's premier contract research organizations, supporting the drug development process from early discovery through clinical manufacturing. The company operates across three main business segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Solutions. With operations in over 20 countries and serving clients ranging from emerging biotech companies to large pharmaceutical corporations, Charles River plays a critical role in the global drug development ecosystem.

Comprehensive contract research organization platform providing integrated drug discovery, development, and manufacturing services including research models, safety assessment, and biologics manufacturing capabilities.

1 drug in pipeline

Total raised: $572M

Competes with large CROs like Labcorp/Covance and IQVIA, as well as specialized providers like WuXi AppTec and Eurofins Scientific. Differentiates through comprehensive early-stage focus, integrated service offerings, and high-quality research models.